Skip to content

Effects of magnesium sulfate in prevention of shivering during spinal anesthesia in cesarean section

Comparison effects of magnesium sulfate and placebo in prevention of shivering during spinal anesthesia in cesarean section

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201308254780N4
Enrollment
80
Registered
2013-09-05
Start date
2012-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal anesthesia. Other complications of spinal and epidural anaesthesia during pregnancy

Interventions

Intervention 1: Intervention group: received 30mg/kg Magnesium sulfate ( dilute it in 50 cc normal saline). Intervention 2: Control group: received 50 cc of normal saline.
Treatment - Drugs
Placebo
Intervention group: received 30mg/kg Magnesium sulfate ( dilute it in 50 cc normal saline)
Control group: received 50 cc of normal saline

Sponsors

Vice Chancellor for Research, Mashhad University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: caesarean section under spinal anesthesia in a Pregnant women with ASA I. Exclusion criteria: ASAII and above; Fever before surgery(T>38) and Hypothermia(T<36.5); Absolute prohibition for spinal anesthesia; Allergy to case study drugs; Thyroid Disease; Parkinson; Raynaud's syndrome; Ischemic heart disease; cerebrovascular disorders; Intraoperative blood transfusion; time of surgery more than 120 minutes; administration of Magnesium; administration of of pethidine; Hypertension; renal disease; history of use of cardiac and Hypertension drug.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Shiver. Timepoint: During opreation every 15 minutes to 120 minutes. Method of measurement: Rate of Crossely & Mahajan.;Temperature. Timepoint: Befor spinal anesthesia and every 15 minutes to 120 minutes during surgery. Method of measurement: Genius 2 Electronic Thermometer.

Secondary

MeasureTime frame
Blood pressure. Timepoint: Every 15 minutes to 120 minutes during surgery. Method of measurement: Non-invasive with Cuff.;Heart rate. Timepoint: Every 15 minutes to 120 minutes during surgery. Method of measurement: monitoring.;Nausea & Vomiting. Timepoint: Every 15 minutes to 120 minutes during surgery. Method of measurement: Observation and question.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammad Alipour

Mashhad University of Medical Sciences

Alipourm@mums.ac.ir+98 51 1801 2612

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026